SCHEMBL3972704

SCHEMBL3972704

CCCCC[C@@H](CC)[C@@H](C)CN

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.46
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
SPHK1 Q9NYA1 1/20 0.39
TP53 P04637 1/20 0.38
DNM1 Q05193 4/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 1/20 0.35
EPHX1 P07099 1/20 0.35
TRPM8 Q7Z2W7 2/20 0.34
CA1 P00915 1/20 0.34
S1PR2 O95136 1/20 0.33
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3972702 1.00 OPRM1 (0.46) OPRM1ALDH1A1TDP1SPHK1TP53
SCHEMBL21670398 0.98 OPRM1 (0.44) OPRM1ALDH1A1TDP1SPHK1DNM1
SCHEMBL10655473 0.93 ALDH1A1 (0.50) OPRM1ALDH1A1TDP1SPHK1DNM1
SCHEMBL19173931 0.88 OPRM1 (0.48) OPRM1ALDH1A1TDP1SPHK1TP53
SCHEMBL4451994 0.88 OPRM1 (0.48) OPRM1ALDH1A1TDP1SPHK1TP53
SCHEMBL24919993 0.88 OPRM1 (0.48) OPRM1ALDH1A1TDP1SPHK1TP53
SCHEMBL14252507 0.88 OPRM1 (0.48) OPRM1ALDH1A1TDP1SPHK1TP53
SCHEMBL18922330 0.88 OPRM1 (0.48) OPRM1ALDH1A1TDP1SPHK1TP53
SCHEMBL19173897 0.88 OPRM1 (0.48) OPRM1ALDH1A1TDP1SPHK1TP53
Hydrochloric Acid SCHEMBL5604401 0.86 OPRM1 (0.46) OPRM1ALDH1A1TDP1SPHK1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633697-B1 METHOD FOR THE PRODUCTION OF SUBSTITUTED 3-ARYL-BUTYL AMINE COMPOUNDS GRUENENTHAL GMBH (DE) 2009-03-11 EP disclosed
US-7417170-B2 Process for the preparation of substituted 3-aryl-butylamine compounds GRUENENTHAL GMBH (DE) 2008-08-26 US disclosed
US-20060194988-A1 Process for the preparation of substitued 3-aryl-butylamine compounds GRUENENTHAL GMBH 2006-08-31 US disclosed
EP-1633697-A1 METHOD FOR THE PRODUCTION OF SUBSTITUTED 3-ARYL-BUTYL AMINE COMPOUNDS Grünenthal GmbH (DE) 2006-03-15 EP disclosed
WO-2004108658-A1 METHOD FOR THE PRODUCTION OF SUBSTITUTED 3-ARYL-BUTYL AMINE COMPOUNDS Grünenthal GmbH (DE) 2004-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194988-A1 Process for the preparation of substitued 3-aryl-butylamine compounds BRD3, TYR, BBOX1 OPRM1 131/4885ALDH1A1 543/4885TDP1 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.